ACCESS Newswire

    / HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines to treat a wide variety of patients suffering from hard-to-treat solid tumors or hematological malignancies, today announced the acceptance of poster presentation at

    / KEMA Labs, the TIC Division of CESI Group, has enhanced its testing capabilities, significantly boosting the development of HVDC technology. With this expansion, KEMA Labs solidifies its position as a leading independent player in the HVDC Cable testing market,

    / Although biologically omnivores, dogs are often labelled as carnivores. Almost never are they considered vegetarians. Yet vegan pet foods (excluding any animal products) are increasingly being developed for environmental and animal welfare reasons. And now a study just published

    / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its Business Update for the fourth quarter of Fiscal Year 2023 ended June 30, 2023.